- Home
- RNG vs OLMA Comparison
RNG vs OLMA Comparison
Compare RNG & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNG | OLMA |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RNG | OLMA |
|---|---|---|
| Price | $25.75 | $26.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | $31.14 | ★ $41.14 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 02-19-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $2,485,621,000.00 | N/A |
| Revenue This Year | $5.73 | N/A |
| Revenue Next Year | $4.37 | N/A |
| P/E Ratio | $186.71 | ★ N/A |
| Revenue Growth | ★ 5.45 | N/A |
| 52 Week Low | $20.59 | $2.86 |
| 52 Week High | $36.43 | $36.26 |
Technical Indicators
Market Signals| Indicator | RNG | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 31.03 | 50.84 |
| Support Level | $28.14 | $26.93 |
| Resistance Level | $30.03 | $29.50 |
| Average True Range (ATR) | 1.18 | 1.61 |
| MACD | -0.37 | -0.19 |
| Stochastic Oscillator | 3.35 | 54.42 |
Price Performance
Historical ComparisonAbout RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.